Potassium chloride medications recalled over ‘failed dissolution’ [Video]

Two brands of potassium chloride capsules are being recalled because they may not dissolve as they should, which could cause a person to have a heart attack, according to the Food and Drug Administration (FDA).

In a press release published on June 25, the FDA explained that Glenmark Pharmaceuticals Inc. is recalling 114 batches of a product called Potassium Chloride Extended-Release Capsules, USP (750 mg) 10 mEq K. The reason is because of “failed dissolution” in the pills.

The product is intended for patients who suffer from low potassium levels, or hypokalemia. 

According to the FDA, the failed dissolution could elevate consumers’ potassium to the point where a heart attack is possible.

VIRAL HOSTAGE TAPE SLEEPING TREND GAINS STEAM AS DOCTORS WARN OF POTENTIAL DANGERS

American Health Packaging issued a similar recall of 21 batches of the same capsules. The capsules were also made by Glenmark but distributed by BluePoint Laboratories.

“The failed dissolution of potassium chloride extended …